Title of article :
Personalized Medicine: Pharmacogenomics and Drug Development
Author/Authors :
Mirsadeghi، Somayeh نويسنده Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Mirsadeghi, Somayeh , Larijani، Bagher نويسنده ,
Issue Information :
ماهنامه با شماره پیاپی 0 سال 2017
Pages :
16
From page :
150
To page :
165
Abstract :

Personalized medicine aims is to supply the proper drug to the proper patient within the right dose. Pharmacogenomics (PGx) is to recognize genetic variants that may influence drug efficacy and toxicity. All things considered, the fields cover a wide area, including basic drug discovery researches, the genetic origin of pharmacokinetics and pharmacodynamics, novel drug improvement, patient genetic assessment and clinical patient administration. At last, the objective of Pharmacogenomics is to anticipate a patient’s genetic response to a particular drug as a way of presenting the best possible medical treatment. By predicting the drug response of an individual, it will be possible to increase the success of therapies and decrease the incidence of adverse side effect.

Journal title :
Acta Medica Iranica
Serial Year :
2017
Journal title :
Acta Medica Iranica
Record number :
2404564
Link To Document :
بازگشت